Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: Brain Injuries

Treatments: Drug: Nucleo CMP Forte

Study type: Interventional

Funder types: Other

Identifiers

NCT04499755

KFS protocol

Details and patient eligibility

About

Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Full description

The study aims to study the Efficacy of Nucleo CMP Forte in Traumatic Brain Injury in Pediatrics

Enrollment: 100 estimated patients

Sex: All

Ages: Under 18 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Children with traumatic brain injury: Moderate and Severe.

Exclusion criteria

• Underlying CNS disorders,

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Triple Blind

---

100 participants in 2 patient groups

Nucleo CMP forte

Experimental group

Description:

Nucleo CMP forte twice daily for 6 weeks with supportive treatment.

Treatment:

Drug: Nucleo CMP Forte

Supportive treatment

No Intervention group

Description:

Supportive treatment only.